SMS plant passed FDA inspection; Eisai uses sea shipping for many APIs;

> Japanese drugmaker Eisai is sending about 60% of its Indian-made APIs by ship while Hospira ($HSP) ships its by air. Report

> Indian API maker SMS Pharmaceuticals said a plant in Vizianagaram in Andhra Pradesh has passed a U.S. FDA inspection. Report

> Small Indian drug companies are weighing the benefits and risks of meeting international manufacturing standards. Story

> The Indian government intends to invest some money in public manufacturing facilities in its effort to help wean the country off foreign-made APIs. Report

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.